Baxter International stock heads into the open after a modest gain
Published on 09/10/2026 at 06:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Baxter International stock closed at USD 40.34 on the New York Stock Exchange on September 9, 2026, edging up about 0.1 percent from the prior session. Compared with the broader S&P 500, which fell 0.48% to 7,636.46 on September 9, 2026, Baxter International outperformed the index on a day when equities came under pressure from surging oil prices.
September 9, 2026 in numbers
Baxter International Inc. (ISIN US0673431090) ended the September 9, 2026 session at USD 40.34, within a daily range that kept the close between the day's low and high as reported in NYSE quote data. Trading volume on the same date matched typical recent levels for the stock, while the close remained within its published 52 week range, indicating that the move was incremental rather than extreme in the current year. The S&P 500 declined 0.48% to 7,636.46 points on September 9, 2026 as oil prices moved above 100 dollars per barrel, a backdrop that weighed on many large caps but left Baxter International relatively resilient, according to Kitco.
Sector sentiment around healthcare and medical technology was supported by Baxter International's participation in a major industry event. As Seeking Alpha reported, Baxter International Inc. was scheduled to present at the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026 at 12:45 PM Eastern Time, an appearance that highlighted ongoing efforts to improve growth and advance its turnaround narrative and helped frame investor discussions during the session.
Outlook today
Today, September 10, 2026, Baxter International continues to be in focus for analysts following its conference commentary and the path of its earnings expectations. According to MarketBeat, at least one analyst recently raised the forecast for Baxter International's third quarter earnings per share and the shares carry a consensus Hold rating with an average target price of USD 22.45, figures that may shape expectations ahead of the next results release. More broadly, the stock enters today's session against a backdrop of elevated oil prices and recent declines in major United States equity indices, with the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite all closing lower on September 9, 2026 as higher energy costs and macro concerns pressured risk assets, per Seoul Economic Daily. In this environment, Baxter International's healthcare exposure and updated earnings forecasts are key reference points for today's trading.
